Actively Recruiting
Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection
Led by The First Hospital of Jilin University · Updated on 2026-03-25
115
Participants Needed
1
Research Sites
148 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The effectiveness of Patellin ® antibacterial solution in treating persistent cervical HR-HPV infection
CONDITIONS
Official Title
Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 25 to 65 years (inclusive)
- Persistent cervical HR-HPV infection for at least 2 years with the same high-risk HPV subtype
- If cervical biopsy is done, it shows chronic cervicitis or low-grade cervical intraepithelial neoplasia
- Sexual history recorded
- No anti-HPV treatment (vaginal or systemic) within 3 months before the visit
- No pregnancy plan within 6 months after the visit
- Voluntary signing of informed consent
You will not qualify if you...
- Cervical biopsy results indicating TCT or high-grade squamous intraepithelial lesion (HSIL)
- Change or reversal to negative of cervical HR-HPV infection subtype
- Pregnant or breastfeeding women
- Acute inflammation of the genital tract
- Recent immunodeficiency such as chemoradiotherapy, AIDS, or systemic lupus erythematosus
- Severe diseases including diabetes, cardiovascular, brain, liver, kidney, hematopoietic system disorders, or mental illness
- History of drug allergy or allergic constitution
- Participation in other clinical trials within the last 3 months
- Suspected or confirmed history of alcohol or drug abuse
- Other conditions reducing enrollment possibility or complicating follow-up (e.g., unstable living or work environment) as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Hospital of Jilin University
Changchun, Jilin, China, 130000
Actively Recruiting
Research Team
X
Xiaosen Li Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here